Regulus Therapeutics
RGLS
#6948
Rank
A$0.85 B
Marketcap
A$12.31
Share price
0.00%
Change (1 day)
416.51%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: A$0.85 Billion

As of December 2025 Regulus Therapeutics has a market cap of A$0.85 Billion. This makes Regulus Therapeutics the world's 6948th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.85 B425.65%
2024A$0.16 B326.84%
2023A$37.99 M12.07%
2022A$33.9 M-46.54%
2021A$63.42 M-43.11%
2020A$0.11 B317.29%
2019A$26.71 M129.37%
2018A$11.64 M-91.59%
2017A$0.13 B-16.17%
2016A$0.16 B-73.8%
2015A$0.63 B-34.28%
2014A$0.95 B177.08%
2013A$0.34 B59.38%
2012A$0.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
A$148.98 B 17,377.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$177.13 B 20,679.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$38.24 B 4,386.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$423.23 B 49,549.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
A$77.97 B 9,046.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.22 B-73.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$165.73 B 19,342.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.49 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA